The effect of ubiquinone in diabetic polyneuropathy: A randomized double-blind placebo-controlled study?

Twelve weeks treatment with ubiquinone improves clinical outcomes and nerve conduction parameters of diabetic polyneuropathy; furthermore, it reduces oxidative stress without significant adverse events (Diabetes and Its Complications)